Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma

NCT01541332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Pegylated Liposomal Doxorubicin (PLD)
DRUG: Dexamethasone

Sponsor

Oncotherapeutics

Collaborators

[object Object]